TXNIP and gastric cancer: Several lines of evidence also suggest that the loss of TXNIP is involved in the progression of bladder and hepatocellular carcinoma13, while higher TXNIP levels are associated with a better prognosis in breast and gastric cancers, as well as in diffuse large B cell lymphoma14–16.